Click to copy
Click to copy

Esperion Therapeutics: 2Q Earnings Snapshot

August 8, 2019

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $54.2 million in its second quarter.

On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $2.01.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.86 per share.

The biopharmaceutical company posted revenue of $982,000 in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $933,000.

Esperion Therapeutics shares have fallen 16% since the beginning of the year. The stock has fallen 17% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

All contents © copyright 2019 The Associated Press. All rights reserved.